Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/29/2025

Treatment of Urethritis with Symptoms but No Leukocytospermia

Diagnostic Criteria

  • The Centers for Disease Control and Prevention recommends confirming urethritis through proper urethral testing, not semen analysis, using criteria such as mucopurulent or purulent urethral discharge, Gram stain of urethral secretions showing ≥5 WBCs per oil immersion field, positive leukocyte esterase test on first-void urine, or microscopic examination of first-void urine showing ≥10 WBCs per high-power field 2, 4
  • The absence of white blood cells in semen is not relevant for diagnosing urethritis, and semen analysis is used to evaluate fertility or prostatitis, not urethritis 2, 4

Treatment Algorithm

  • The Centers for Disease Control and Prevention recommends treating empirically with azithromycin 1g orally as a single dose or doxycycline 100mg orally twice daily for 7 days while awaiting test results for gonorrhea and chlamydia 1, 2, 5
  • Azithromycin has the advantage of being a single-dose treatment, ensuring compliance and allowing directly observed therapy, and is particularly effective against Mycoplasma genitalium 1, 2, 3
  • Doxycycline is highly effective for chlamydial urethritis, but requires patient compliance with a multi-day regimen 1, 2, 3

Management of Persistent or Recurrent Symptoms

  • If symptoms persist after initial treatment, re-confirm objective signs of urethritis, rule out non-compliance or partner reinfection, test for Trichomonas vaginalis, and consider tetracycline-resistant Ureaplasma urealyticum 6, 7
  • The recommended treatment for persistent/recurrent urethritis is metronidazole 2g orally as a single dose or tinidazole 2g orally as a single dose, plus azithromycin 1g orally as a single dose (if not used initially) 6, 7

Partner Management

  • All sexual partners within the preceding 60 days must be evaluated and treated, and should receive treatment effective against chlamydia regardless of whether a specific pathogen is identified 3, 5, 7
  • Both patient and partners should abstain from sexual intercourse until 7 days after therapy is initiated and symptoms have resolved 6

Follow-Up

  • Patients should return if symptoms persist or recur after treatment, and test-of-cure is not recommended for asymptomatic patients who received recommended treatment 1, 3, 5
  • Consider repeat testing 3-6 months after treatment due to high reinfection rates 3